Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX in Adult Post-Stroke Lower Limb Spasticity
NCT01575054Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2012
- Primary completion
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
Phase 3, randomised, double-blind trial in spasticity comparing BOTOX with Placebo (2 arms). Primary endpoint: Modified Ashworth Scale-Bohannon at 6 weeks. Started May 2012; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01575054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575054.